Category: Advancements in Alzheimers disease

The new test could also help confirm whether Alzheimer’s or another condition is causing a person’s symptoms.

New tests of blood and spinal fluid can show how far Alzheimer’s has progressed and how fast a patient’s memory will decline.

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.

Study pegs certain cellular activities to driving Alzheimer’s disease. Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.